cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Vectivbio Holding Ag
2 own
1 watching
Current Price
$8.15
$0.09
(1.11%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
180.61M
52-Week High
52-Week High
9.45
52-Week Low
52-Week Low
3.81
Average Volume
Average Volume
0M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization180.61M
icon52-Week High9.45
icon52-Week Low3.81
iconAverage Volume0M
iconDividend Yield--
iconP/E Ratio--
What does the Vectivbio Holding Ag do?
VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions. It develops apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 that is in Phase III clinical trial for the treatment of patients with short bowel syndrome-intestinal failure (SBS-IF), as well as apraglutide is in Phase II clinical trial for SBS-IF in patients with colon-in-continuity anatomy. The company is also developing apraglutide, which is in Phase II clinical trial for patients with steroid-refractory gastrointestinal acute versus host disease (aGvHD). The company was incorporated in 2019 and is headquartered in Basel, Switzerland.
Read More
News & Events about Vectivbio Holding Ag.
Globe Newswire
9days ago
Single-dose study to assess pharmacokinetics, pharmacological activity, safety and tolerability in healthy Japanese men and womenBASEL, Switzerland, March 13, 2023 (GLOBE NEWSWIRE) -- VectivBio Holding AG (VectivBio) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel ...
Globe Newswire
4 months ago
BASEL, Switzerland, Nov. 09, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (VectivBio) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, today announced that Luca Santarelli, M.D., Ph.D., Founder and Chief Executive ...
Globe Newswire
5 months ago
BASEL, Switzerland, Oct. 12, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (VectivBio) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, today published the date of the Extraordinary General Meeting, which will be held...
Globe Newswire
9 months ago
Combined Gross Proceeds from Public Offering and Private Sale Total $50 MillionBASEL, Switzerland, June 14, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (VectivBio) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, ...
Globe Newswire
9 months ago
Interim proof-of-concept data anticipated from STARGAZE in H1 2023 First-in-class regenerative, non-immunosuppressive approach to treating acute Graft-versus-Host Disease Second clinical indication under evaluation for apraglutide, demonstrating broad potential of this next generation GLP-2 analog ...
Frequently Asked Questions
Frequently Asked Questions
What is Vectivbio Holding Ag share price today?
plus_minus_icon
Can Indians buy Vectivbio Holding Ag shares?
plus_minus_icon
How can I buy Vectivbio Holding Ag shares from India?
plus_minus_icon
Can Fractional shares of Vectivbio Holding Ag be purchased?
plus_minus_icon
What are the documents required to start investing in Vectivbio Holding Ag stocks?
plus_minus_icon
What is today’s traded volume of Vectivbio Holding Ag?
plus_minus_icon
What is today’s market capitalisation of Vectivbio Holding Ag?
plus_minus_icon
What is the 52-Week High and Low Range of Vectivbio Holding Ag?
plus_minus_icon
What percentage is Vectivbio Holding Ag down from its 52-Week High?
plus_minus_icon
What percentage is Vectivbio Holding Ag up from its 52-Week Low?
plus_minus_icon
Current Price
$8.15
$0.09
(1.11%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00